| Title: | Ranitidine Use and Cancer Risk: Results From UK Biobank |
| Journal: | Gastroenterology |
| Published: | 29 Dec 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33385434/ |
| DOI: | https://doi.org/10.1053/j.gastro.2020.12.037 |
| URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/8035224 |
| Citations: | 16 (9 in last 2 years) as of 8 Aug 2024 |
Publication 5638
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
13 Keywords
- Adult
- Aged
- Female
- Histamine H2 Antagonists
- Humans
- Male
- Middle Aged
- Neoplasms
- Ranitidine
- Risk Assessment
- Risk Factors
- Time Factors
- United Kingdom
6 Authors
- Elizabeth D Kantor
- Kelli O'Connell
- Mengmeng Du
- Robin B Mendelsohn
- Peter S Liang
- Lior Z Braunstein
1 Application
| Application ID | Title |
|---|---|
| 19115 | The role of commonly used medications and supplements in cancer prevention and survival |
Enabling scientific discoveries that improve human health